Breaks Categories: News

ThursdayJun 26, 2025 9:30 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the "Oscar of Italian Dermatology" from SIDeMaST for her research on PC111, a first-in-class anti-Fas Ligand monoclonal antibody. The study, published under the title "Blocking soluble Fas Ligand ameliorates pemphigus", confirms PC111’s ability to block blister formation by preventing keratinocyte apoptosis in pemphigus vulgaris. Scinai holds an option to acquire Pincell and is advancing PC111 as a lead asset, emphasizing its potential as a non-immunosuppressive, disease-modifying treatment for severe autoimmune skin conditions. To view the full press release,…

Continue Reading

WednesdayJun 25, 2025 12:24 pm

NetworkNewsBreaks – Channelchek by Noble Highlights Comstock Metals–Virtus Renewables Partnership for Solar Recycling Expansion

Channelchek, a Noble Financial Group, Inc. product and service, highlights the latest strategic developments from companies across the small and microcap space. Comstock Metals has entered a strategic partnership with Virtus Renewables Service Group Inc. to jointly offer recycling, decommissioning, and logistics solutions tailored to the renewable energy sector. By combining Comstock’s certified zero-landfill solar panel recycling capabilities with Virtus’s expertise in solar and battery storage operations, the alliance will provide full-lifecycle, environmentally responsible services across the U.S. renewable market. The partnership builds on Comstock’s April 2025 agreement with RWE Clean Energy, one of the largest renewable operators in the…

Continue Reading

WednesdayJun 25, 2025 11:50 am

NetworkNewsBreaks – Titan Partners Group LLC Leads $200 Million Private Placement for Quantum Computing (NASDAQ: QUBT)

Titan Partners, a division of American Capital Partners, is acting as sole placement agent in a $200 million private placement for Quantum Computing Inc. (NASDAQ: QUBT), an integrated photonics and quantum optics technology company. The offering involves the sale of 14,035,089 shares of common stock to institutional investors at $14.25 per share. Quantum Computing intends to use the proceeds to accelerate commercialization, pursue strategic acquisitions, and support working capital and general corporate needs. To view the full press release, visit https://nnw.fm/N7xCj About Titan Partners Group LLC Titan Partners Group LLC (“Titan Partners”), a division of American Capital Partners, LLC (“ACP”)…

Continue Reading

WednesdayJun 25, 2025 10:44 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Now Accepts Cryptocurrency, Including Bitcoin and $TRUMP Coin, for EV Purchases

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it is now accepting cryptocurrency—including Bitcoin and the $TRUMP meme coin—for purchases of Mullen and Bollinger commercial EVs. One of the few automakers to offer crypto payments, Mullen is also exploring the addition of other meme and stablecoins. The move broadens access to its U.S. safety- and emissions-certified EV lineup, including the Mullen ONE van, Mullen THREE truck, and Bollinger B4 chassis cab, which offers a 185-mile range and 7,325-pound payload capacity. To view the full press release, visit https://nnw.fm/0GBaQ About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive…

Continue Reading

WednesdayJun 25, 2025 10:13 am

NetworkNewsBreaks – HealthLynked Corp. (OTCQB: HLYK) Partners with Endlink to Advance Hospital Data Integration

HealthLynked (OTCQB: HLYK), a healthcare technology and patient engagement company, has announced a strategic partnership with Endlink, a data integration firm led by Rubén Viera. The alliance aims to enhance EMR connectivity and workflow automation across hospital systems, building on Endlink's success in Puerto Rico, where its platform serves over 300,000 members and supports two major hospital systems. Viera, a former executive at McKesson and Greenway Health, brings over 25 years of experience in healthcare IT and will help expand HealthLynked’s capabilities in real-time data integration and patient-centered care. The collaboration also creates opportunities to deploy HealthLynked's tools—like AI-driven insights…

Continue Reading

WednesdayJun 25, 2025 9:15 am

NetworkNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening System across Sweden, Norway, and Denmark, with Finland showing rising interest. The technology offers a less invasive, hygienic alternative to urine and saliva tests, delivering results in under 10 minutes and gaining traction in sectors like logistics, education, and criminal justice. Spjotgard’s growing regional presence and strategic alliances position INBS to scale further in Northern Europe. To view the full article, visit https://nnw.fm/OJGaN About Intelligent…

Continue Reading

TuesdayJun 24, 2025 3:28 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights GBM Treatment Insights in KOL Segment Featuring Dr. Erin Dunbar 

CNS Pharmaceuticals (NASDAQ: CNSP) announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, Director of Neuro-Oncology at Piedmont Atlanta Hospital and founding physician of its Brain Tumor Center. Dr. Dunbar discussed the patient journey and current treatment options for Glioblastoma Multiforme (GBM), highlighting CNS’s lead product candidate, TPI 287, and its therapeutic potential for GBM and future metastatic tumor indications. To view the full press release, visit https://nnw.fm/MBIkc About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of…

Continue Reading

TuesdayJun 24, 2025 2:45 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model 

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with high unmet medical needs, announced new preclinical data showing that INM-901 significantly reduces inflammation in ex vivo models of neuroinflammation. The compound demonstrated a dose-dependent and statistically significant reduction in pro-inflammatory cytokines IL-6, IL-1β, IL-2, KC/Gro, and inflammasome marker NLRP3—key factors in Alzheimer’s disease progression. Notably, the effects were independent of amyloid beta or tau pathology, highlighting INM-901’s broader potential in treating neurodegenerative diseases. The orally administered compound also targets CB1/CB2 receptors and PPARs and has shown improvements in cognition and behavior in long-term animal…

Continue Reading

TuesdayJun 24, 2025 12:57 pm

NetworkNewsBreaks – Fusion Fuel Green PLC (NASDAQ: HTOO) Subsidiary Secures $1.2 Million in New UAE Energy Projects 

Fusion Fuel Green (NASDAQ: HTOO) i.e., Fusion Fuel, announced its majority-owned subsidiary, Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), secured AED 4.4 million (~$1.2 million USD) in new engineering and utility projects across Dubai. The new awards include developments in Dubai Marina, Business Bay, Satwa, and other districts, adding to the more than $2.7 million in contracts previously disclosed in May. All projects will generate recurring revenue through long-term utility agreements. Al Shola Gas’s customer base now exceeds 12,000, with bulk LPG volumes over 600 metric tons monthly and a year-end target of 800 metric tons. Executives…

Continue Reading

TuesdayJun 24, 2025 10:45 am

NetworkNewsBreaks – BioAdaptives, Inc. (OTC Pink: BDPT) to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum

BioAdaptives (OTC Pink: BDPT), a leader in nutraceutical and wellness innovation, will launch its proprietary canine supplement Pawpa(TM) Regen nationwide by the end of July 2025. Designed to support natural stem cell activation in aging dogs, the supplement has shown promising results in early trials, including improved energy, mobility, coat quality, and temperament. CEO James Keener emphasized the product’s unique regenerative approach using safe, naturally sourced ingredients. With strong early feedback and growing demand for holistic pet care solutions, BioAdaptives is expanding production ahead of the broader e-commerce rollout. To view the full press release, visit https://nnw.fm/4ys2R About BioAdaptives, Inc.…

Continue Reading